Ascentage Pharma Group International
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $298,878 | $334,132 | $334,132 | $233,699 |
Gross Profit | 250,864 | 265,447 | 265,447 | 212,049 |
EBITDA | -701,075 | -598,953 | -598,953 | -510,033 |
EBIT | -743,951 | -640,854 | -640,854 | -553,984 |
Net Income | -807,679 | -639,957 | -639,957 | -590,768 |
Net Change In Cash | 298,878 | 334,132 | 334,132 | 233,699 |
Free Cash Flow | -612,310 | -787,407 | -787,407 | -452,157 |
Cash | 1,896,253 | 2,471,657 | 2,471,657 | 1,661,454 |
Basic Shares | 93,312 | 92,603 | 92,603 | 85,397 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $558,478 | $980,650 | $221,984 | $209,711 |
Gross Profit | 426,749 | 951,565 | 191,441 | 187,713 |
EBITDA | -1,092,681 | -237,631 | -743,610 | -771,472 |
EBIT | -1,179,161 | -330,800 | -836,805 | -834,387 |
Net Income | -1,208,909 | -405,433 | -925,637 | -882,924 |
Net Change In Cash | 558,478 | 980,650 | 221,984 | 209,711 |
Free Cash Flow | -1,201,699 | -135,646 | -782,921 | -890,878 |
Cash | 2,471,657 | 1,236,578 | 1,069,296 | 1,475,639 |
Basic Shares | 89,032 | 75,515 | 17,643 | 16,479 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-09-30 | -$0.42 |
2025-06-30 | -$1.73 |
2025-03-31 | -$1.82 |